Gene · 1848
Papers2,747
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,747
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Investigating protein degradability through site-specific ubiquitin ligase recruitment. | RSC Chem Biol | 2025 | 39711601 | PubTator, text mining | PubMed |
| PEGylated Titanium Dioxide Nanoparticle-bound Doxorubicin and Paclitaxel Drugs Affect Prostate Cancer Cells and Alter the Expression of DUSP Family Genes. | Anticancer Agents Med Chem | 2025 | 39473102 | PubTator, text mining | PubMed |
| Multi-omics and bioinformatics for the investigation of therapeutic mechanism of roucongrong pill against postmenopausal osteoporosis. | J Ethnopharmacol | 2025 | 39362330 | PubTator, text mining | PubMed |
| DNA methylation and histone modifications associated with antipsychotic treatment: a systematic review. | Mol Psychiatry | 2025 | 39227433 | PubTator, text mining | PubMed |
| A monoamine oxidase B inhibitor altered gene expression of catalytically active dual-specificity phosphatases in human oral gingival keratinocytes. | Eur Rev Med Pharmacol Sci | 2024 | 39749374 | PubTator, text mining | PubMed |
| Role of Protein Tyrosine Phosphatases in Inflammatory Bowel Disease, Celiac Disease and Diabetes: Focus on the Intestinal Mucosa. | Cells | 2024 | 39682729 | PubTator, text mining | PubMed |
| [DUSP6, a potential target to prevent leukemic progression in myeloproliferative neoplasms]. | Med Sci (Paris) | 2024 | 39656988 | PubTator, text mining | PubMed |
| Investigating Protein Degradability through Site-Specific Ubiquitin Ligase Recruitment. | bioRxiv | 2024 | 39605659 | PubTator, text mining | PubMed |
| Chronic Inflammatory Pain Alters Expression of Limbic MAPK Phosphatases. | Chronic Pain Manag | 2024 | 39574961 | PubTator, text mining | PubMed |
| DUSP6 regulates Notch1 signalling in colorectal cancer. | Nat Commun | 2024 | 39572549 | PubTator, text mining | PubMed |
| Utility of patient-derived xenografts to evaluate drug sensitivity and select optimal treatments for individual non-small-cell lung cancer patients. | Mol Med | 2024 | 39528952 | PubTator, text mining | PubMed |
| Hippocampal cannabinoid type 2 receptor alleviates chronic neuropathic pain-induced cognitive impairment via microglial DUSP6 pathway in rats. | FASEB J | 2024 | 39498753 | PubTator, text mining | PubMed |
| Exploring the Mechanism of Sempervirine Inhibiting Glioblastoma Invasion Based on Network Pharmacology and Bioinformatics. | Pharmaceuticals (Basel) | 2024 | 39458959 | PubTator, text mining | PubMed |
| A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer. | Lung Cancer | 2024 | 39383771 | PubTator, text mining | PubMed |
| ASCL1 Restrains ERK1/2 to Promote Survival of a Subset of Neuroendocrine Lung Cancers. | Mol Cancer Ther | 2024 | 39295275 | PubTator, text mining | PubMed |
| Physics-driven unsupervised deep learning network for programmable metasurface-based beamforming. | iScience | 2024 | 39246440 | PubTator, text mining | PubMed |
| DUSP6 protein action and related hub genes prevention of sepsis-induced lung injury were screened by WGCNA and Venn. | Int J Biol Macromol | 2024 | 39197622 | PubTator, text mining | PubMed |
| WT1 together with RUNX1::RUNX1T1 targets DUSP6 to dampen ERK activity in acute myeloid leukaemia. | Br J Haematol | 2024 | 39191510 | PubTator, text mining | PubMed |
| Prostaglandin D2 receptor 2 downstream signaling and modulation of type 2 innate lymphoid cells from patients with asthma. | PLoS One | 2024 | 39052598 | PubTator, text mining | PubMed |
| In vivo vitamin D target genes interconnect key signaling pathways of innate immunity. | PLoS One | 2024 | 39042613 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1848/papers?page=5